Patient-Centered Approach for Treatment Decisions in Mitral Valve Prolapse

Conditions

• Mitral Valve Prolapse

Eligibility Criteria

Sex

ALL

Age

21 Years - N/A

Healthy Volunteers

Not accepted

Interventions

• Focus Groups/Quantitative Survey for Patients — OTHER
  5 quantitative focus groups will be conducted with 5-10 patients each to elicit the range of outcomes patients consider important when selecting treatment options. 100 quantitative surveys to characterize how patients with severe MR prioritize outcomes when making treatment decisions.
• Focus Group/Quantitative Survey for HCPs — OTHER
  5 quantitative focus groups will be conducted with 5-10 providers to elicit the range of outcomes providers consider important when recommending treatment options to patients. 100 quantitative surveys to characterize how providers prioritize outcomes for patients with severe MR when making treatment recommendations.
• Qualitative Focus Group — OTHER
  Qualitative focus groups will be conducted to determine barriers and facilitators to implementing shared decision making in multidisciplinary mitral valve heart team clinics.

Study Details

This is a qualitative and quantitative study that seeks to obtain information from patients with degenerative mitral valve prolapse and providers regarding factors important in deciding between surgical mitral valve repair (MVR) and transcatheter edge-to-edge repair (TEER). Findings from this study will provide data that can be used to develop decision aids that can assist patients in decision making between these two therapies and assist providers in integrating shared decision making the within the multidisciplinary heart valve team.

Key Dates

Start date

Sep 1, 2023

Status verified

Dec 2024

Primary completion

Jan 28, 2024

Completion

Feb 28, 2025

Study Design

Enrollment

150 participants (estimated)

Arms

• Arm: Patients with MR
  We will recruit patients with degenerative mitral regurgitation (MR) who are presenting to a surgeon or cardiologist for consultation regarding management of their valve disease.
• Arm: Health Care Providers
  We will recruit Health Care providers (cardiac surgeons and cardiologists) who evaluate and treat patients with mitral regurgitation.
• Arm: Multidisciplinary Mitral Valve Heart Team
  We will recruit members of multidisciplinary mitral valve heart teams including cardiac surgeons, cardiologists, nurses, and ancillary staff. These providers will be involved in caring for patients who presents to multidisciplinary heart teams for evaluation of their mitral valve disease.

Primary Outcome Measure

Identify outcomes most important to patients with severe degenerative MR considering TEER or MVR [ Time Frame: 1 year ]

Central Contacts

• Nancy Stone, MEd, NBC-HWC
  816-932-5367
  [email protected]
• Shangyi Liu, MS
  516-757-5949
  [email protected]

Locations (5)

Find similar trials in Los Angeles, CA

Related Studies

• PRIMARY Ancillary Substudy
  Recruiting · Annetine Gelijns · Los Angeles, California